ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

Cancer Advocates Ask House By Byspass Budget; NCCR’s Day Calls For $380 Mil. Minimum Increase

March 12, 1993

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974

Cancer Meetings Listed For Next Three Months

June 25, 1993